Contrary to conventional medical wisdom, metformin compares favorably with insulin for controlling blood sugar in A2 gestational diabetes—GD with elevated fasting blood sugar levels.
Contrary to conventional medical wisdom, metformin compares favorably with insulin for controlling blood sugar in A2 gestational diabetes-GD with elevated fasting blood sugar levels.
Researchers randomized women at less than 36 weeks' gestation to achieve normal blood sugar levels by either subcutaneous insulin injection (0.7 units) or 500 mg of metformin, with the goal of attaining postprandial blood glucose readings of less than 120 mg/dL and fasting blood sugars of between 60 and 90 mg/dL. Pregnant women were excluded from the study if they had conditions like insulin-dependent diabetes mellitus, chronic hypertension, or seizure disorders.
Thirty-one patients received insulin injection and 32 metformin. Those receiving the latter weighed about 30 lb more than the other group. Glucose levels were similar in each group and actually somewhat lower in the metformin group 2 hours after lunch (mean 106 vs. 112.5) and 2 hours after dinner (mean 108.1 vs. 109.2). There was little difference in abdominal delivery rates, shoulder dystocia, and postpartum hemorrhage and no differences in newborn statistics between the two groups, nor in birthweight, Apgar score at 5 minutes, or NICU admission.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More